Indiana takes on powerful hospitals by capping prices they charge employers
medicalxpress - Tired of watching its employers struggle to afford the cost of health care, Republican-controlled Indiana is trying a traditionally liberal tactic to control costs: setting government price controls on hospitals.
AI Summary: Indiana enacted legislation capping the prices hospitals can charge employers, a bold move aimed at reining in dominant health systems that have long driven up commercial costs. The measure forces hospitals to accept lower, more predictable rates for employer-covered care, prompting industry pushback as the state tries to rebalance bargaining power.
DOJ announces $6.5B healthcare fraud takedown with record Medicaid enforcement
fiercehealthcare - Law enforcement unveiled charges against 455 defendants for their alleged participation in healthcare schemes, among which fraudulent amniotic wound allografts and undelivered Medicaid services were spotlighted.
AI Summary: The Department of Justice announced a sweeping $6.5 billion healthcare fraud enforcement action, charging multiple defendants in schemes involving fraudulent billing, shell companies and luxury purchases. The coordinated takedown underscores ongoing federal efforts to police Medicare and Medicaid fraud and recover misspent taxpayer funds.
- Corporate Civil Suits and Settlements in Healthcare Fraud (3)
- Mass DOJ Takedown: 455 Charged in $6.5B Fraud (5)
Corporate Civil Suits and Settlements in Healthcare Fraud
Mass DOJ Takedown: 455 Charged in $6.5B Fraud
Unpacking CMS' decision to recalculate 2026 MA star ratings after Clover Health ruling
fiercehealthcare - A recent court ruling in favor of Clover Health is leading the feds to recalculate Medicare Advantage's star ratings for 2026, and analysts at Capstone warn that this "foreshadows [a] volatile direction" for the program.
AI Summary: CMS announced a recalculation of Medicare Advantage star ratings in response to legal rulings involving Clover Health, adjusting the methodology used to score plan performance. The agency’s decision affects plan quality ratings and related payments, prompting insurers and stakeholders to reassess expectations ahead of the updated reporting and reimbursement cycle.